1. Nexus BioPharma, Inc. Appoints Daniel Einhorn, M.D. to Scientific & Clinical Advisory Board

    Nexus BioPharma, Inc. Appoints Daniel Einhorn, M.D. to Scientific & Clinical Advisory Board

    Nexus BioPharma, Inc.,, a company specializing in the development of a weight loss drug therapy, announced today the appointment of Daniel Einhorn , M.D. to the Company's Scientific & Clinical Advisory Board. Dr. Einhorn is medical director of the Scripps Whittier Diabetes Institute, Clinical Professor of Medicine (voluntary) at UC San Diego, President of Diabetes and Endocrine Associates, and Associate Editor of the Journal of Diabetes ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. We are thrilled that Dan is joining our team of advisors.
    2. We need better tools to manage obesity and metabolic diseases, like diabetes.
  3. Topics Mentioned